Group One Trading
ARKG icon

Group One Trading’s ARK Genomic Revolution ETF ARKG Stock Holding History

Group One Trading’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5M Buy
118,863
+73,002
+159% +$2.32M 0.01% 1432
2026
Q1 		$1.21M Buy
45,861
+28,765
+168% +$842K ﹤0.01% 2532
2025
Q4 		$495K Sell
17,096
-109,304
-86% -$3.28M ﹤0.01% 3523
2025
Q3 		$3.51M Buy
126,400
+33,022
+35% +$834K 0.01% 1803
2025
Q2 		$2.27M Buy
+93,378
New +$2.05M 0.01% 2016
2025
Q1 		– Sell
-16,949
Closed -$426K – 7547
2024
Q4 		$399K Buy
+16,949
New +$417K ﹤0.01% 3361

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Group One Trading's ARKG Position: Q2 2026 in Review

Group One Trading increased its ARK Genomic Revolution ETF (ARKG) stake by 159% in Q2 2026, buying an estimated $2.32M and bringing the position to 118,863 shares worth $5M. The position accounts for 0.01% of the portfolio, ranked #1432.

Group One Trading first reported a position in ARKG in Q4 2024 and has held it in 6 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Group One Trading held 118,863 shares of ARK Genomic Revolution ETF worth $5M as of Q2 2026.
  • Group One Trading bought 73,002 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $2.32M.
  • ARK Genomic Revolution ETF made up 0.01% of Group One Trading's portfolio in Q2 2026, its #1432 holding.
  • Group One Trading first reported a position in ARK Genomic Revolution ETF in Q4 2024 and has held it in 6 quarters since.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.